Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 529

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients With Acute Ischemic Stroke: The DEVT Randomized Clinical Trial

Open access
Zi, Wenjie, Qiu, Zhongming, Li, Fengli, Sang, Hongfei, Wu, Deping, Luo, Weidong, Liu, Shuai, Yuan, Junjie, Song, Jiaxing, Shi, Zhonghua, Huang, Wenguo, Zhang, Min, Liu, Wenhua, Guo, Zhangbao, Qiu, Tao, Shi, Qiang, Zhou, Peiyang, Wang, Li, Fu, Xinmin, Liu, Shudong, Yang, Shiquan, Zhang, Shuai, Zhou, Zhiming, Huang, Xianjun, Wang, Yan, Luo, Jun, Bai, Yongjie, Zhang, Min, Wu, Youlin, Zeng, Guoyong, Wan, Yue, Wen, Changming, Wen, Hongbin, Ling, Wentong, Chen, Zhuo, Peng, Miao, Ai, Zhibing, Guo, Fuqiang, Li, Huagang, Guo, Jing, Guan, Haitao, Wang, Zhiyi, Liu, Yong, Pu, Jie, Wang, Zhen, Liu, Hansheng, Chen, Luming, Huang, Jiacheng, Yang, Guoqiang, Gong, Zili, Shuai, Jie, Nogueira, Raul G., Yang, Qingwu, DEVT Trial Investigators·2021·JAMA

Abstract

Importance: For patients with large vessel occlusion strokes, it is unknown whether endovascular treatment alone compared with intravenous thrombolysis plus endovascular treatment (standard treatment) can achieve similar functional outcomes. Objective: To investigate whether endovascular thrombectomy alone is noninferior to intravenous alteplase followed by endovascular thrombectomy for achieving functional independence at 90 days among patients with large vessel occlusion stroke. Design, Setting, and Participants: Multicenter, randomized, noninferiority trial conducted at 33 stroke centers in China. Patients (n = 234) were 18 years or older with proximal anterior circulation intracranial occlusion strokes within 4.5 hours from symptoms onset and eligible for intravenous thrombolysis. Enrollment took place from May 20, 2018, to May 2, 2020. Patients were enrolled and followed up for 90 days (final follow-up was July 22, 2020). Interventions: A total of 116 patients were randomized to the endovascular thrombectomy alone group and 118 patients to combined intravenous thrombolysis and endovascular thrombectomy group. Main Outcomes and Measures: The primary end point was the proportion of patients achieving functional independence at 90 days (defined as score 0-2 on the modified Rankin Scale; range, 0 [no symptoms] to 6 [death]). The noninferiority margin was -10%. Safety outcomes included the incidence of symptomatic intracerebral hemorrhage within 48 hours and 90-day mortality. Results: The trial was stopped early because of efficacy when 234 of a planned 970 patients had undergone randomization. All 234 patients who were randomized (mean age, 68 years; 102 women [43.6%]) completed the trial. At the 90-day follow-up, 63 patients (54.3%) in the endovascular thrombectomy alone group vs 55 (46.6%) in the combined treatment group achieved functional independence at the 90-day follow-up (difference, 7.7%, 1-sided 97.5% CI, -5.1% to ∞)P for noninferiority = .003). No significant between-group differences were detected in symptomatic intracerebral hemorrhage (6.1% vs 6.8%; difference, -0.8%; 95% CI, -7.1% to 5.6%) and 90-day mortality (17.2% vs 17.8%; difference, -0.5%; 95% CI, -10.3% to 9.2%). Conclusions and Relevance: Among patients with ischemic stroke due to proximal anterior circulation occlusion within 4.5 hours from onset, endovascular treatment alone, compared with intravenous alteplase plus endovascular treatment, met the prespecified statistical threshold for noninferiority for the outcome of 90-day functional independence. These findings should be interpreted in the context of the clinical acceptability of the selected noninferiority threshold. Trial Registration: Chinese Clinical Trial Registry: ChiCTR-IOR-17013568.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2020.23523

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 529

Metadata

Authors
Zi, W., Qiu, Z., Li, F., Sang, H., Wu, D., Luo, W., Liu, S., Yuan, J., Song, J., Shi, Z., Huang, W., Zhang, M., Liu, W., Guo, Z., Qiu, T., Shi, Q., Zhou, P., Wang, L., Fu, X., Liu, S., Yang, S., Zhang, S., Zhou, Z., Huang, X., Wang, Y., Luo, J., Bai, Y., Zhang, M., Wu, Y., Zeng, G., Wan, Y., Wen, C., Wen, H., Ling, W., Chen, Z., Peng, M., Ai, Z., Guo, F., Li, H., Guo, J., Guan, H., Wang, Z., Liu, Y., Pu, J., Wang, Z., Liu, H., Chen, L., Huang, J., Yang, G., Gong, Z., Shuai, J., Nogueira, R. G., Yang, Q., & DEVT Trial Investigators
Venue
JAMA
Published
2021-01-19
Volume
325
Issue
3
Pages
234
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W3123951518
Cited by
529
References
22
FWCI
62.35
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients With Acute Ischemic Stroke: The DEVT Randomized Clinical Trial. https://app.cochat.ai/papers/10.1001/jama.2020.23523
The paper
Zi, W., Qiu, Z., Li, F., Sang, H., Wu, D., Luo, W., Liu, S., Yuan, J., Song, J., Shi, Z., Huang, W., Zhang, M., Liu, W., Guo, Z., Qiu, T., Shi, Q., Zhou, P., Wang, L., Fu, X., . . . DEVT Trial Investigators. (2021). Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients With Acute Ischemic Stroke: The DEVT Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2020.23523

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.